子宫肌瘤,神经生长因子,转化生长因子 -β1,复发,预测 ," /> 子宫肌瘤,神经生长因子,转化生长因子 -β1,复发,预测 ,"/> Uterine fibroids,Nerve growth factor,Transforming growth factor-β1,Recurrence,Prediction ,"/> <div> <span style="font-size:14px;line-height:2;">腹腔镜下子宫肌瘤剔除术后患者 NGF、TGF-β1 表达及其与术后复发的关系</span> </div>
Please wait a minute...
欢迎访问发育医学电子杂志,今天是
发育医学电子杂志  2026, Vol. 14 Issue (3): 237-242,256    DOI: 10.3969/j.issn.2095-5340.2026.03.010
  生长发育   论著 |
腹腔镜下子宫肌瘤剔除术后患者 NGF、TGF-β1 表达及其与术后复发的关系
李燕 王洋 戎瑞爽 李梅 李赫 王晓倩 尹会文
1. 衡水市第二人民医院 妇科,河北 衡水 053000;2. 衡水市第二人民医院 腺体外科,河北 衡
水 053000;3. 衡水市第二人民医院 麻醉科,河北 衡水 053000;4. 衡水市第二人民医院 妇产科,河北 衡水 053000;5. 衡水市第二人民医院 感染科,河北 衡水 053000
Expression of NGF and TGF-β1 in patients after laparoscopic myomectomy and their relationship with postoperative recurrence
Li Yan , Wang Yang, Rong Ruishuang , et al.
1.Department of Gynecology, the Second People's Hospital of Hengshui, Hengshui, Hebei 053000, China; 2. Department of Glandular Surgery, the Second People's Hospital of Hengshui, Hengshui, Hebei 053000, China; 3. Department of Anesthesiology, the Second People's Hospital of Hengshui, Hengshui, Hebei 053000, China; 4. Department of Obstetrics and Gynecology, the Second People's Hospital of Hengshui, Hengshui, Hebei 053000, China; 5. Department of Infectious Diseases, the Second People's Hospital of Hengshui, Hengshui, Hebei 053000, China)
下载:  PDF (1142KB) 
输出:  BibTeX | EndNote (RIS)      
摘要 
目的 分析腹腔镜下子宫肌瘤剔除术后患者神经生长因子(nerve growth factor,NGF)、转化生长因子 -β1(transforming growth factor-β1,TGF-β1)表达水平及其与术后复发的关系。方法 采用前瞻性队列研究方法,选取 2023 年 1 月至 11 月于衡水市第二人民医院接受腹腔镜下子宫肌瘤剔除术的 212 例子宫肌瘤患者作为研究对象,术后随访 12 个月,根据患者术后复发情况将其分为复发组(n=43)和未复发组(n=169)。对比 2 组患者的临床资料;检测术前、术后 1 个月 2 组患者的血清 NGF、TGF-β1 表达水
平;采用受试者工作特征(receiver operating characteristics,ROC)曲线分析血清 NGF、TGF-β1 表达水
平对患者术后复发的预测效能;采用 Spearman 秩相关分析血清 NGF、TGF-β1 表达水平与肌瘤个数、
最大径的相关性;采用多因素 Logistic 回归分析筛选腹腔镜下子宫肌瘤剔除术后患者复发的影响因素。
统计学方法采用独立样本 t 检验、χ2 检验。结果 与未复发组相比,复发组中肌瘤数量 >2 个、肌瘤最
大径 >5 cm 占比均明显较高(P 值均 <0.05),2 组患者年龄、身体质量指数、子宫肌瘤家族史、初潮年龄、肌瘤位置、术后妊娠等方面差异均无统计学意义(P 值均 >0.05)。2 组患者术前的血清 NGF、TGF-β1
表达水平比较差异均无统计学意义(P 值均 >0.05),2 组患者术后的 NGF、TGF-β1 表达水平均较术前显著降低(P 值均 <0.05),且未复发组低于复发组(P 值均 <0.05)。ROC 曲线分析结果显示,血清 NGF、TGF-β1 表达水平预测患者术后复发的曲线下面积(area under the curve,AUC)分别为 0.869、0.865,敏感度分别为 86.05%、81.40%,特异度分别为 86.39%、87.57% ;两者联合预测的 AUC 值为 0.951,均高于
NGF(Z=2.958,P=0.003)与 TGF-β1(Z=2.896,P=0.004)单独预测,敏感度和特异度分别为 76.74%、
97.63%。Spearman 秩相关分析结果显示,血清 NGF、TGF-β1 表达水平与肌瘤个数均呈正相关(r
为 0.421、0.368,P 值均 <0.001),与肌瘤最大径均无显著相关性(r 值为 0.126、0.203,P 值均>0.05);多因素 Logistic 回归分析结果发现,肌瘤数量 >2 个、肌瘤最大径 >5 cm、血清 NGF、TGF-β1 表达水平升高均为患者术后复发的独立危险因素(P 值均 <0.05)。结论 腹腔镜下子宫肌瘤剔除术后患者血清 NGF、
TGF-β1 表达水平均明显降低,且 2 种因子均对预测患者术后复发有一定的价值,两者联合预测的价值更为突出。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
关键词:  子宫肌瘤')" href="#">    
Abstract: 
Objective To analyze the expression levels of nerve growth factor (NGF) and transforming growth factor-β1 (TGF-β1) in patients after laparoscopic myomectomy and their relationship with postoperative recurrence. Methods A prospective cohort study was conducted, a total of 212 patients with uterine fibroids who underwent laparoscopic myomectomy in the Second People's Hospital of Hengshui from January to November 2023 were enrolled, and were followed up for 12 months after surgery. According to the postoperative recurrence of patients, the patients were divided into recurrence group (n=43) and non-recurrence group (n=169). The clinical data of the two groups were compared; the serum expression levels of NGF and TGF-β1 in the two groups before and 1 month after surgery were detected; receiver operating characteristic (ROC) curve was drawn to analyze the predictive efficacy of serum NGF and TGF-β1 expression levels on postoperative recurrence, Spearman rank correlation analysis was used to investigate the correlations between serum NGF, TGF-β1 expression levels and the number and maximum diameter of fibroids; multivariate Logistic regression analysis was used to screen the factors affecting the postoperative recurrence of patients after laparoscopic myomectomy. Statistical analysis was performed using the independent sample t-test and χ2 test. Results Compared with the non-recurrence group, the proportions of patients with the number of fibroids >2 and maximum diameter of fibroids >5 cm in the recurrence group were significantly higher (all P<0.05). There were no significant differences in age, body mass index, family history of uterine fibroids, age of menarche, location of fibroids and postoperative pregnancy between the two groups (all P>0.05). There were no significant differences in serum NGF and TGF-β1 levels between the two groups before surgery (all P>0.05), and the expression levels of NGF and TGF-β1 in the two groups after surgery were significantly lower than those before surgery (all P<0.05), and the levels in the non-recurrence group were lower than those in the recurrence group (all P<0.05).
ROC curve analysis showed that the area under the curve (AUC) of postoperative recurrence predicted
by serum NGF and TGF-β1 expression levels was 0.869 and 0.865, the sensitivity was 86.05% and
81.40%, and the specificity was 86.39% and 87.57%, respectively. The AUC predicted by both methods
was 0.951, which was higher than NGF (Z=2.958, P=0.003) and TGF-β1 (Z=2.896, P=0.004) alone,
and the sensitivity and specificity were 76.74% and 97.63%, respectively. Spearman rank correlation
analysis showed that serum NGF and TGF-β1 expression levels were positively correlated with the number of fibroids (r values were 0.421, 0.368, all P<0.001), while they were not significantly correlated with the maximum diameter of fibroids (r values were 0.126, 0.203, all P>0.05). Multivariate Logistic regression analysis showed that the number of fibroids >2, the maximum diameter of fibroids >5cm, and the increase of serum NGF and TGF-β1 were all independent risk factors for postoperative recurrence in patients (all P<0.05). Conclusion The expression levels of serum NGF and TGF-β1 in patients after laparoscopic myomectomy significantly decreased. Both of these factors have certain value in predicting postoperative recurrence of the patients, and the combination of the two factors has even greater predictive value.
Key words:  Uterine fibroids')" href="#">
收稿日期:  2025-03-11                出版日期:  2026-05-30      发布日期:  2026-05-30      期的出版日期:  2026-05-30
基金资助: 
衡水市 2024 年度第一批科技计划(自筹经费)项目(2024014003Z) 
通讯作者:  李燕    E-mail:  qzqyhzwowk@163.com
引用本文:    
李燕 王洋 戎瑞爽 李梅 李赫 王晓倩 尹会文.
腹腔镜下子宫肌瘤剔除术后患者 NGF、TGF-β1 表达及其与术后复发的关系
[J]. 发育医学电子杂志, 2026, 14(3): 237-242,256.
Li Yan , Wang Yang, Rong Ruishuang , et al..
Expression of NGF and TGF-β1 in patients after laparoscopic myomectomy and their relationship with postoperative recurrence
. Journal of Developmental Medicine(Electronic Version), 2026, 14(3): 237-242,256.
链接本文:  
http://www.fyyxzz.com/CN/10.3969/j.issn.2095-5340.2026.03.010  或          http://www.fyyxzz.com/CN/Y2026/V14/I3/237
[1] 王娇 李素叶 焦艳 王磊 崔家璐 冀雪霞 张聪祎. AT- Ⅲ、D- 二聚体和血小板聚集率联合维生素 D 在复发性流产中的预测价值[J]. 发育医学电子杂志, 2026, 14(1): 13-19.
[2] 李寅 李继英 胡红文 罗芳. 3D-PDUS 血流参数对宫腔镜下重度宫腔黏连分解术后复发的预测价值[J]. 发育医学电子杂志, 2024, 12(3): 204-209.
[3] 胡乔飞 罗岚蓉. 复发性流产患者子宫内膜容受性分子生物学研究进展[J]. 发育医学电子杂志, 2023, 11(6): 456-460,465.
[4] 辛亚维 王龙斌 张步美 王建梅 顾艳. MicroRNA 在胎盘发育及复发性流产中的研究进展[J]. 发育医学电子杂志, 2023, 11(1): 60-64.
[5] 靳元元 李铭德 刘洋 张建军. p53 基因介导的细胞凋亡与复发性流产的研究进展[J]. 发育医学电子杂志, 2022, 10(4): 315-320.
[6] 朱大华 陈家莲 胡洋 夏雪 赵雪 郭贝西 牟华平. HPV DNA 检测、HPV E6/E7 mRNA 检测和液基薄层细胞学检查对宫颈切除术后病灶残留或复发的预测价值[J]. 发育医学电子杂志, 2022, 10(3): 203-208.
[7] 梁建梅 卢雪景 刘晓旭 秦丽欣 王亚凡. 甲状腺自身抗体阳性对复发性流产的临床意义[J]. 发育医学电子杂志, 2021, 9(5): 341-345.
[8] 卢雪景 梁建梅 申林林 白娅琴 秦丽欣 高金霞 王亚凡. 低分子肝素联合小剂量阿司匹林对复发性流产患者血栓前状态、肝功能及免疫功能的影响[J]. 发育医学电子杂志, 2021, 9(3): 214-219.
[9] 席栋 郑玉花. 小儿急慢性胰腺炎的研究进展[J]. 发育医学电子杂志, 2020, 8(1): 92-96.
[10] 刘盾 关怀 尚丽新. 复发性流产免疫学病因及诊治进展[J]. 发育医学电子杂志, 2019, 7(1): 55-59.
[11] 刘盾 关怀. 复发性流产的病因及治疗进展[J]. 发育医学电子杂志, 2018, 6(4): 208-212.
[12] 朱丽娜 辜蕊洁 马秀伟 等. 鼠神经生长因子治疗中枢性协调障碍的疗效观察[J]. 发育医学电子杂志, 2017, 5(4): 229-232.
[13] 于若寒 孙琳 刘湘源. 产科抗磷脂综合征与复发性流产的研究进展[J]. 发育医学电子杂志, 2017, 5(2): 122-125.
No Suggested Reading articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed